{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:24:47Z","timestamp":1788477887056,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.urology.2024.11.056","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:54:42Z","timestamp":1733064882000},"page":"119-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22\u00a0BladderChek, UBC\u00a0Rapid Test, CancerCheck\u00a0UBC Rapid VISUAL, and Uromonitor\u00a0in Comparison to Cytology"],"prefix":"10.1016","volume":"197","author":[{"given":"Thorsten H.","family":"Ecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Meisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Rabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Labont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Friedersdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilli","family":"Sommerfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nella","family":"Gagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"G\u00f6ssl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Barski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla M.","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Niegisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.P.","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario W.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Roggisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Veltrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Eidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph M.","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.11.056_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA\u00a0Cancer\u00a0J Clin"},{"key":"10.1016\/j.urology.2024.11.056_bib2","first-page":"1","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Dr\u00e4ger","year":"2015","journal-title":"Urol\u00a0Int"},{"key":"10.1016\/j.urology.2024.11.056_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.11.056_bib4","first-page":"1689","article-title":"Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer","volume":"163","author":"Raitanen","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib5","first-page":"374","article-title":"Human complement factor H related protein test for monitoring bladder cancer","volume":"165","author":"Raitanen","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0090-4295(97)00292-6","article-title":"Improved detection of recurrent bladder cancer using the Bard BTA stat Test","volume":"50","author":"Sarosdy","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.11.056_bib7","first-page":"E347","article-title":"Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: a\u00a0meta-analysis","volume":"8","author":"Guo","year":"2014","journal-title":"Can\u00a0Urol\u00a0Assoc J"},{"key":"10.1016\/j.urology.2024.11.056_bib8","first-page":"363","article-title":"Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment","volume":"156","author":"Soloway","year":"1996","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.eururo.2005.09.002","article-title":"Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer","volume":"48","author":"Moonen","year":"2005","journal-title":"Eur Urol"},{"issue":"6 Suppl 1","key":"10.1016\/j.urology.2024.11.056_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.11.056_bib11","doi-asserted-by":"crossref","first-page":"66.e25","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2024.11.056_bib12","first-page":"S53","article-title":"Diagnosis of urothelial carcinoma from urine","volume":"22","author":"T\u00eatu","year":"2009","journal-title":"Mod\u00a0Pathol\u00a0Offl\u00a0J\u00a0United States Can\u00a0Acad\u00a0Pathol\u00a0Inc"},{"key":"10.1016\/j.urology.2024.11.056_bib13","first-page":"9","article-title":"A review of reporting systems and terminology for urine cytology","volume":"121","author":"Owens","year":"2013","journal-title":"Cancer\u00a0Cytopathol"},{"key":"10.1016\/j.urology.2024.11.056_bib14","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/cancers15082341","article-title":"Surveillance of low-grade non-muscle invasive bladder tumors using uromonitor: SOLUSION trial","volume":"15","author":"Azawi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.urology.2024.11.056_bib15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","article-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines","volume":"65","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib16","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms19123841","article-title":"UBC((R)) Rapid Test-A Urinary Point-of-Care (POC) assay for diagnosis of bladder cancer with a focus on non-muscle invasive high-grade tumors: results of a multicenter-study","volume":"19","author":"Ecke","year":"2018","journal-title":"Int J\u00a0Mol Sci"},{"key":"10.1016\/j.urology.2024.11.056_bib17","first-page":"45","article-title":"The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies","volume":"26","author":"Raitanen","year":"2008","journal-title":"World\u00a0J\u00a0Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.19929","article-title":"Urinary UBC rapid and NMP22 test for bladder cancer surveillance in comparison to urinary cytology: results from a prospective single-center study","volume":"14","author":"Pichler","year":"2017","journal-title":"Int J\u00a0Med Sci"},{"key":"10.1016\/j.urology.2024.11.056_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.urolonc.2013.09.024","article-title":"Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer","volume":"32","author":"Ritter","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2024.11.056_bib20","first-page":"293","article-title":"Evaluation of the diagnostic accuracy of UBC((R)) Rapid in bladder cancer: a Swedish multicentre study","volume":"51","author":"Styrke","year":"2017","journal-title":"Scand J\u00a0Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib21","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.urology.2024.11.056_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0970-1591.166448","article-title":"Biomarkers for non-muscle invasive bladder cancer: current tests and future promise","volume":"31","author":"Darwiche","year":"2015","journal-title":"Indian J Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30538-7","article-title":"TERT mutations in urine could predict bladder cancer recurrence","volume":"18","author":"Gourd","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2024.11.056_bib24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3389\/fgene.2019.01237","article-title":"Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study","volume":"10","author":"Batista","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.urology.2024.11.056_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.11.056_bib26","first-page":"754","article-title":"Nomograms including the UBC(\u00ae) Rapid test to detect primary bladder cancer based on a multicentre dataset","volume":"130","author":"Meisl","year":"2022","journal-title":"BJU\u00a0Int"},{"key":"10.1016\/j.urology.2024.11.056_bib27","first-page":"1119","article-title":"Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity","volume":"108","author":"Kamat","year":"2011","journal-title":"BJU\u00a0Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524011130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524011130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:43:12Z","timestamp":1742013792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429524011130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"alternative-id":["S0090429524011130"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.11.056","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22\u00a0BladderChek, UBC\u00a0Rapid Test, CancerCheck\u00a0UBC Rapid VISUAL, and Uromonitor\u00a0in Comparison to Cytology","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}